Perceptive Advisors - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 21 filers reported holding ANI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$8,992,000
+9.1%
7,500,0000.0%0.21%
-11.2%
Q1 2019$8,239,000
+11.6%
7,500,0000.0%0.23%
-17.4%
Q4 2018$7,383,000
-7.0%
7,500,0000.0%0.28%
+32.5%
Q3 2018$7,942,000
-6.1%
7,500,0000.0%0.21%
-4.5%
Q2 2018$8,458,000
+3.0%
7,500,0000.0%0.22%
-3.5%
Q1 2018$8,214,000
-5.0%
7,500,0000.0%0.23%
-19.6%
Q4 2017$8,642,000
-46.8%
7,500,000
-50.0%
0.29%
-7.7%
Q3 2017$16,238,000
+105.3%
15,000,000
+100.0%
0.31%
-22.1%
Q2 2017$7,908,000
-0.6%
7,500,0000.0%0.40%
-12.1%
Q1 2017$7,958,000
-8.5%
7,500,0000.0%0.45%
-26.8%
Q4 2016$8,700,000
-6.2%
7,500,0000.0%0.62%
+3.3%
Q3 2016$9,279,000
+14.3%
7,500,0000.0%0.60%
+6.4%
Q2 2016$8,121,000
+23.2%
7,500,0000.0%0.56%
-2.6%
Q1 2016$6,590,000
-11.7%
7,500,0000.0%0.58%
+4.7%
Q4 2015$7,461,000
-46.1%
7,500,000
-50.0%
0.55%
-0.2%
Q3 2015$13,846,000
+63.1%
15,000,000
+100.0%
0.55%
+8.2%
Q2 2015$8,488,000
-1.5%
7,500,0000.0%0.51%
-23.7%
Q1 2015$8,621,000
+9.3%
7,500,0000.0%0.67%
+1.4%
Q4 2014$7,885,0007,500,0000.66%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Wellesley Asset Management 59,455$68,522,0003.54%
DLD Asset Management, LP 4,500,000$5,185,0001.70%
Worth Venture Partners, LLC 945,000$1,100,0001.18%
Perceptive Advisors 7,500,000$8,700,0000.62%
WOLVERINE ASSET MANAGEMENT LLC 15,439,000$17,789,0000.23%
Allianz Asset Management GmbH 35,165,000$40,795,0000.04%
GABELLI FUNDS LLC 1,500,000$1,740,0000.01%
AQR Arbitrage LLC 525,000$605,0000.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 9,000,000$10,328,0000.01%
Edge Advisors, LLC 33,000$38,0000.01%
View complete list of ANI PHARMACEUTICALS INC shareholders